Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Five-Year Survival With Combined Nivolumab and Ipilimumab in Advanced MelanomaN. Engl. J. Med 2019 Sep 28;[EPub Ahead of Print], J Larkin, V Chiarion-Sileni, R Gonzalez, JJ Grob, P Rutkowski, CD Lao, CL Cowey, D Schadendorf, J Wagstaff, R Dummer, PF Ferrucci, M Smylie, D Hogg, A Hill, I Márquez-Rodas, J Haanen, M Guidoboni, M Maio, P Schöffski, MS Carlino, C Lebbé, G McArthur, PA Ascierto, GA Daniels, GV Long, L Bastholt, JI Rizzo, A Balogh, A Moshyk, FS Hodi, JD Wolchok
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.